Skip to main content

Our Partners

 Explore new currents from our partners

June 8, 2022

Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

Read More

Read More

August 9, 2021 Remembering Catalys Pacific Industry Advisor…

We are deeply saddened by the sudden passing of our dear Advisor, Dr. Tachi Yamada. Tachi was incremental to the founding vision of Catalys Pacific …

Continue reading “Remembering Catalys Pacific Industry Advisor Tadataka ‘Tachi’ Yamada, MD (1945-2021)”

Read More

May 14, 2019 Takeda and Frazier Healthcare Partners…

New Company and Collaboration To Develop Novel Therapeutics Including Vonoprazan for the Treatment of Acid-Related Disorders in North America and Europe Cambridge, Mass. and Menlo …

Continue reading “Takeda and Frazier Healthcare Partners Announce Collaboration to Launch Phathom Pharmaceuticals”